Moderna Lyme Disease Vaccine Research Study   With protective steps that aren’t completely effective, Lyme disease is calling for a new solution. The Canopy Trial is evaluating two investigational vaccines to see if we can potentially prevent Lyme disease and worry less about ticks. This clinical trial is looking for adult participants. To join, you must be: Age18 through 70 years of age In good health Not pregnant or planning on becoming pregnant for at least 3 months following the final vaccine visit Prior to enrolling in this clinical trial, you cannot have: Chronic illness related to Lyme disease or an active Lyme disease infection Received treatment for Lyme disease within 3 months Had a previous vaccine against Lyme disease Had a tick bite within 4 weeks   Qualified participants will receive payment for their trial-related time and travel.  
Read more.

Lyme disease is a tick-borne illness that can cause serious long-term symptoms if left untreated Currently, there are no approved vaccines available to prevent Lyme disease in people exposed to ticks that carry Lyme disease. This clinical trial will evaluate if an investigational (study) vaccine is safe and effective in preventing Lyme disease. This study may be an option for healthy adults and children over 5 who live in areas where ticks that carry Lyme disease are found and frequently participate in activities that may put them in contact with ticks: Outdoor occupations such as landscaping, forestry, or wildlife and parks management Frequent outdoor recreational activities such as hiking, camping, fishing, hunting, or gardening Living in or frequently visiting wooded areas, tree lines, tall grass, open fields, lake sides, or riversides Owning a pet that may return from outdoors with attached ticks These are not the only eligibility criteria for this clinical research study. A clinical research team member will help determine if this
Read more.

At this time, there is  no approved or authorized Covid-19 protection for babies under 6 months old, leaving them vulnerable at daycare, at family functions, and even at home as older siblings head back to school. The vaccine being evaluated in the BabyCOVE Study is Moderna’s “bivalent” (addressing 2 viral strains at the same time) investigational COVID-19 vaccine. It is being evaluated at 2 dosing levels to find out which is the safest and most effective dose for infants.
Read more.

We're looking for healthy adolescent volunteers to participate in a clinical trial of an investigational mRNA vaccine to  protect against mono. Must be age 12 to 17 Other criteria apply Volunteers are compensated for participation
Read more.